Max Hodak’s Science Corp. is preparing to place its first sensor in a human brain

image via TechCrunch

April 14, 2026, 5:13 PM

• •Science Corp. is developing a biohybrid brain-computer interface.
• •The device will use lab-grown neurons integrated with electronics.
• •The initial trials will focus on patients who need brain surgery.
• •The ultimate goal is to treat neurological disorders and enhance human capabilities.

Science Corp., founded by former Neuralink president Max Hodak, is preparing for the first U.S. human trials of its biohybrid brain-computer interface, led by neurobiologist Dr. Murat Günel. The company, valued at $1.5 billion after a recent funding round, aims to create a device that combines lab-grown neurons with electronics to treat neurological conditions and potentially enhance human capabilities. Unlike Neuralink's direct brain insertion, Science's sensor will be placed on top of the brain, initially targeting patients needing brain surgery for safety and efficacy testing. The long-term goal is to address conditions like Parkinson's disease by combining electronics with biological systems to potentially halt disease progression.

Read original article